Apogee Receives Research Grant for Arthritis Work

Apogee Biotechnology Corporation has received a Phase II Small Business Innovation Research grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.

This award, in the amount of nearly $1 million, will fund the preclinical studies of the sphingosine kinase inhibitor platform in models of rheumatoid arthritis and osteoarthritis.

Powered by THE BRAVO GROUP & ARCHODA: CREATE SOMETHING UNIQUE